The Munich-based startup Inveox, founded in 2017 by Maria and Dominik Sievert, aims to use digital solutions to improve the transport of tissue samples from the doctor to the laboratory, as well as the processing of information related to these digital samples. Sample processing and analysis is prone to irregularities. For example, it can happen that tissue samples are mixed up during manual labeling or marking. In the worst case, this can lead to a misdiagnosis and subsequent incorrect or no treatment for patients.
Digital workflow solutions such as Roche's Vantage Workflow Solution help prevent such errors. However, their use previously required a connection to the respective laboratory information system (LIS). However, since some pathology laboratories do not have this connection, Roche Diagnostics Germany and Inveox have jointly developed an alternative to the LIS connection. For this purpose, Inveox has implemented a sample entry module that allows Roche's workflow solution to be used independently of the LIS used.
Inveox: “A strong cooperation partner at our side”
Roche Diagnostics Germany is the German division of the Swiss company Roche Diagnostics International, which in turn is a subsidiary of Hoffmann-La Roche. The parent company, headquartered in Basel, is considered the world's largest pharmaceutical company by revenue. Christian Paetzke, Managing Director of Roche Diagnostics Germany explains:
“Thanks to the successful collaboration with Inveox, our digital workflow solution is now accessible to all customers and offers the opportunity to further improve the quality of diagnostics.”
Dominik Sievert, founder and managing director of Inveox, welcomes the cooperation as a continuation of a productive relationship spanning several years:
“I greatly appreciate that, as a young, up-and-coming medtech company, we have a strong cooperation partner in Roche, and I am delighted to be working with Roche to advance digital diagnostics in histopathology.”
In 2018, the pharmaceutical company Roche, together with the seed investor Plug and Play, launched the Digital Health Accelerator Startup Creasphere Inveox was part of the program's Batch Zero. In addition to Munich, the startup also operates subsidiaries in Krakow, Poland, and Houston, Texas, USA. The company currently has a total of 89 employees across all locations.
